Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Blairex Labs Acquires Thompson Medical Supplements And OTCs

This article was originally published in The Tan Sheet

Executive Summary

Blairex Labs has purchased Thompson Medical Company's remaining product lines including the Nature's Reward dietary supplement line, Aqua Ban, an OTC diuretic, Sleepinal, an OTC sleep aid, Encare vaginal contraceptive suppositories and Breath Free.

You may also be interested in...



Heritage Acquires N'ICE, Cepastat Throat Drops From SmithKline Beecham

Heritage Consumer Products is adding SmithKline Beecham's N'ICE and Cepastat throat lozenges to its cold/allergy product group, the companies announced Jan. 22. Details of the agreement were not disclosed.

Chattem's Dexatrim Purchase Makes It Top OTC Diet Aid Marketer

Chattem's acquisition of the Dexatrim OTC diet aid line and the analgesic rubs Sportscreme, Aspercreme, Capzasin-P, Capzasin-HP and Arthritis Hot from Thompson Medical moves the company into the top ranks in both categories, Chattem said.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS090527

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel